Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 2 Step Approach to Haploidentical Transplant Using Radiation-Based Reduced Intensity Conditioning

NCT05031897 is registered in ClinicalTrials.gov with Thomas Jefferson University as lead sponsor.

NCT NCT05031897
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05031897 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 2 Step Approach to Haploidentical Transplant Using Radiation-Based Reduced Intensity Conditioning
Lead sponsor
Thomas Jefferson University
Phase
Phase 2
Overall status
Recruiting
Start date
October 25, 2021
Completion date
April 30, 2032
Enrollment
63 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia, acute myeloid leukemia, adult t-cell leukemia/lymphoma, aplastic anemia, chronic lymphocytic leukemia, chronic myeloid leukemia, bcr-abl1 positive, chronic myelomonocytic leukemia, essential thrombocythemia, hematopoietic and lymphatic system neoplasm, hodgkin lymphoma, multiple myeloma, myelodysplastic syndrome, myelofibrosis, myeloid neoplasm, non-hodgkin lymphoma, polycythemia vera, small lymphocytic lymphoma